Author:
Kristiansen G,Rose M,Geisler C,Fritzsche F R,Gerhardt J,Lüke C,Ladhoff A-M,Knüchel R,Dietel M,Moch H,Varga Z,Theurillat J-P,Gorr T A,Dahl E
Publisher
Springer Science and Business Media LLC
Reference52 articles.
1. Arcasoy MO, Amin K, Karayal AF, Chou SC, Raleigh JA, Varia MA, Haroon ZA (2002) Functional significance of erythropoietin receptor expression in breast cancer. Lab Invest 82: 911–918
2. Bhargava R, Beriwal S, Dabbs DJ, Ozbek U, Soran A, Johnson RR, Brufsky AM, Lembersky BC, Ahrendt GM (2010) Immunohistochemical surrogate markers of breast cancer molecular classes predicts response to neoadjuvant chemotherapy: a single institutional experience with 359 cases. Cancer 116: 1431–1439
3. Brown JM (1999) The hypoxic cell: a target for selective cancer therapy--eighteenth Bruce F. Cain Memorial Award lecture. Cancer Res 59: 5863–5870
4. Brown JM, Wilson WR (2004) Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer 4: 437–447
5. Brunori M (2001) Nitric oxide moves myoglobin centre stage. Trends Biochem Sci 26: 209–210
Cited by
48 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献